Poitiers University Hospital - Product Pipeline Review - Q4 2010

GlobalData, December 2010, Pages: 40

Poitiers University Hospital – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Poitiers University Hospital – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.

Scope

- Review of therapeutics under development by Poitiers University Hospital.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Poitiers University Hospital with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of Poitiers University Hospital’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.

Reasons to buy

- Identify new drug targets and therapeutic classes in Poitiers University Hospital’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
- Evaluate Poitiers University Hospital’s position with total access to a detailed information on its therapeutic products development.
- Assess the growth potential of Poitiers University Hospital in its therapy areas of focus.
- Exploit collaboration and partnership opportunities with Poitiers University Hospital.
- Avoid Intellectual Property Rights related issues.

List of Tables
List of Figures
Poitiers University Hospital Snapshot
Key Information
Key Facts
Poitiers University Hospital – Research and Development Overview
Key Therapeutic Areas
Poitiers University Hospital – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Poitiers University Hospital – Pipeline Products Glance
Poitiers University Hospital – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Poitiers University Hospital Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Poitiers University Hospital – Drug Profiles
Ciprofloxacine
Product Description
Mechanism of Action
R&D Progress
Omexel + spasfon
Product Description
Mechanism of Action
R&D Progress
STI571 + Cytarabine
Product Description
Mechanism of Action
R&D Progress
STI571 + Peg-Interferon-Alpha2a
Product Description
Mechanism of Action
R&D Progress
STI571 600 mg
Product Description
Mechanism of Action
R&D Progress
Lenalidomide
Product Description
Mechanism of Action
R&D Progress
Mefloquine
Product Description
Mechanism of Action
R&D Progress
mifepristone
Product Description
Mechanism of Action
R&D Progress
Cefotaxime
Product Description
Mechanism of Action
R&D Progress
Ciprofloxacin
Product Description
Mechanism of Action
R&D Progress
Colistin
Product Description
Mechanism of Action
R&D Progress
Ertapenem
Product Description
Mechanism of Action
R&D Progress
Fosfocine
Product Description
Mechanism of Action
R&D Progress
Metronidazole
Product Description
Mechanism of Action
R&D Progress
Poitiers University Hospital – Pipeline Analysis
Poitiers University Hospital – Pipeline Products by Therapeutic Class
Poitiers University Hospital Pipeline Products By Target
Poitiers University Hospital – Pipeline Products by Route of Administration
Poitiers University Hospital – Pipeline Products by Molecule Type
Poitiers University Hospital - Dormant Projects
Poitiers University Hospital – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Customers who bought this item also bought

• eLEARNING - Global Strategic Business Report
• Charter Schools - Global Outlook
• Commercial And Military Flight Simulation - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• Sports and Fitness Nutrition - Global Strategic Business Report
• International Military and Government Helicopter Survey
• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020
• Generic Defense Strategies: Lifecycle Management Strategies to Maximize Revenue in the Face of Growing Generic Competition